(Date:12/1/2008)..., Va., Dec. 1 Two individuals asso...C), in McLean, VA, who survived the Pearl Harbor,... event Sunday, December 7,2008 at the U.S. Navy ...cer,during the attack, another just a young boy. ...es and a national showcase for new methods and tec...
(Date:12/1/2008).... RICHMOND, Calif., Dec. 1 Transce...lty pharmaceutical company, announced today that,... Officer, is scheduled to,participate at the RBC ...York,City on a panel entitled "Delivering Novel D...s presentation is scheduled to take place on Thurs...
(Date:12/1/2008)...t Local Estrogen Therapy Indicated for the Treatme...Pain With Intercourse - Symptoms of Vulvar and Vag...er Expands Company,s Hormone Therapy Product Line ...tCall/ -- Barr Pharmaceuticals, Inc. (NYSE: BRL ...nistration (FDA) has approved its subsidiary Duram...
(Date:12/1/2008)...sed project educates and empowers through personal...ec. 1 Washington D.C.,s...national average in the United States. Of people ...re African American. On Thursday, December 4, in ..., the Southern AIDS Coalition (SAC) and Test for L...
Breaking Medicine News(10 mins):Health News:Individuals Associated with Vinson Hall Retirement Community, Who Survived Pearl Harbor Attack, to Participate in Navy Memorial Event December 7 2Health News:Transcept Pharmaceuticals to Participate on Drug Delivery Investor Panel 2Health News:FDA Approves Duramed's Synthetic Conjugated Estrogens-A Vaginal Cream 2Health News:FDA Approves Duramed's Synthetic Conjugated Estrogens-A Vaginal Cream 3Health News:FDA Approves Duramed's Synthetic Conjugated Estrogens-A Vaginal Cream 4Health News:FDA Approves Duramed's Synthetic Conjugated Estrogens-A Vaginal Cream 5Health News:FDA Approves Duramed's Synthetic Conjugated Estrogens-A Vaginal Cream 6Health News:FDA Approves Duramed's Synthetic Conjugated Estrogens-A Vaginal Cream 7Health News:Southern AIDS Living Quilt Coming to Washington, D.C. 2...icials in Russia have reported to have said that m... by complications, and every second newborn discha...roblems. The number of normal births declined fro...ent last year, said Olga Frolova, head of the stat...
...ntal drug could make millions of people suffering...bstructive Pulmonary Disease (COPD) or smoker’s lu...by narrowing of the airways. It encompasses emphys...involving 500 people who had suffered from COPD fo...
... at the University of Texas Health Science Center ...th in a petri dish from single mouse cells - and t...esearch in the direction where they could take ini...in a culture dish and grow a tooth for them.To acc...
...ic preparation for perennial allergic rhinitis app...ter team studied 50 patients with perennial allerg...ve either 30cc of a homeopathic preparation of pri... and fourth week after the start of treatment, the...
Other Medicine News:(Date:11/25/2008)...ess can improve recovery , , Audio and Web ...ble on the Mayo Clinic News Blog. Please see the b... ROCHESTER, Minn., Nov. 25 /PRNewswire-USNewswire/... patients don,t think they,re having a stroke -- a...eir condition worsens. The findings appear in the ...
(Date:11/25/2008)...if., Nov. 25 Pharmacycli...he company has completed a Phase 1,clinical trial...ss,small-molecule Factor VIIa inhibitor. The tria...s to evaluate the safety and pharmacologic effect ...3 resulted in a linear dose,response in the Inter...
(Date:11/24/2008)...J., Nov. 24 Leaders of S...ovided an update for investors on the company,s re...e portfolio that includes 46 new entities in clini...eclinical studies. , , "Research and develo...lough as we continue our transformation," said Fre...
(Date:11/24/2008)...24 /PRNewswire-FirstCall/ - Predictive medicine co...ced that it has entered into a fully funded collab...gest cosmetic companies. PreMD,s PREVU* skin chole...f the cosmetic company,s skin care products in a E...ccessful study completed by PreMD with the cosmeti...
Breaking Medicine Technology:Do You Know You're Having a Stroke? 2Do You Know You're Having a Stroke? 3Pharmacyclics Announces Completion of Phase 1 Clinical Trial of Factor VIIa Inhibitor PCI-27483 2Pharmacyclics Announces Completion of Phase 1 Clinical Trial of Factor VIIa Inhibitor PCI-27483 3Pharmacyclics Announces Completion of Phase 1 Clinical Trial of Factor VIIa Inhibitor PCI-27483 4Schering-Plough Highlights R&D Pipeline Progress, Innovation and Breadth of Research Projects 2Schering-Plough Highlights R&D Pipeline Progress, Innovation and Breadth of Research Projects 3Schering-Plough Highlights R&D Pipeline Progress, Innovation and Breadth of Research Projects 4Schering-Plough Highlights R&D Pipeline Progress, Innovation and Breadth of Research Projects 5PreMD Inc. Enters Clinical Study with Cosmetics Conglomerate 225 Short Films About Top Level Research on swissinfo ch 9112 125 Short Films About Top Level Research on swissinfo ch 9112 2Phase II Trial of Experimental Anti Coagulant Reports Safety and Outcomes Data 29497 1Phase II Trial of Experimental Anti Coagulant Reports Safety and Outcomes Data 29497 2Phase II Trial of Experimental Anti Coagulant Reports Safety and Outcomes Data 29497 3Phase II Trial of Experimental Anti Coagulant Reports Safety and Outcomes Data 29497 4Quanterix Corporation Announces the Addition of Dr Robert Corn to its Scientific Advisory Board 9111 1Quanterix Corporation Announces the Addition of Dr Robert Corn to its Scientific Advisory Board 9111 2Drug Eluting Stents Beat Bare Metal Stents in Diabetics 29491 1Drug Eluting Stents Beat Bare Metal Stents in Diabetics 29491 2Drug Eluting Stents Beat Bare Metal Stents in Diabetics 29491 3Drug Eluting Stents Beat Bare Metal Stents in Diabetics 29491 4...cose Homeostasis Effects in,Normal and Diabetic Ra...l/ -- In a 14-day,Phase IIa study of the safety p...mpound dapagliflozin, a selective inhibitor of,the... alone or,concomitantly with metformin in subjects...adverse events and no serious adverse,events were ...
...ewswire-FirstCall/ --,Replidyne, Inc. today announ...8839, a novel topical antibiotic that has shown po...s including,methicillin-resistant S. aureus (MRSA)...cally applied REP8839 appears safe,well-tolerated...g,absorption into the bloodstream, which is desira...
Other Medicine Technology:First Phase II Short-Term Study on Dapagliflozin Shows Results on,Safety, Tolerability and Glycemic Markers in Subjects With Type 2,Diabetes 2First Phase II Short-Term Study on Dapagliflozin Shows Results on,Safety, Tolerability and Glycemic Markers in Subjects With Type 2,Diabetes 3First Phase II Short-Term Study on Dapagliflozin Shows Results on,Safety, Tolerability and Glycemic Markers in Subjects With Type 2,Diabetes 4First Phase II Short-Term Study on Dapagliflozin Shows Results on,Safety, Tolerability and Glycemic Markers in Subjects With Type 2,Diabetes 5First Phase II Short-Term Study on Dapagliflozin Shows Results on,Safety, Tolerability and Glycemic Markers in Subjects With Type 2,Diabetes 6Replidyne Announces Positive Phase I Results for Topical Antibiotic,REP8839 2Replidyne Announces Positive Phase I Results for Topical Antibiotic,REP8839 3Replidyne Announces Positive Phase I Results for Topical Antibiotic,REP8839 4... provides service to companies in many different i...res and restaurants.There are no hidden charges at...nd service are among the lowest in the industry. E...from MasterCard/Visa processing to Debit Card Serv...
Paraffin Block Storage System
A histological embedment block cataloging and storage system. This file system incorporates the necessary features offering embedment block protection, simplified cataloging, reduction of filing erro
The Flash MiniLabeler products can be configured to label microplates, tubes, vials, glass slides, circuit boards and a wide array of small products. Systems perform wrap around (tube or package) lab
Medicine Products: